title: Inhibition of apoptosis in human tumour cells by okadaic acid.
abstract: Gamma-radiation, tetrandrine, bistratene A, and cisplatin were all found to induce pronounced morphological changes characteristic of apoptosis and extensive DNA fragmentation in the human BM13674 cell line 8 h after treatment. Apoptosis induced in BM13674 cells by these diverse agents was markedly inhibited by 1 microM okadaic acid, a tumour promoter that inhibits protein phosphatases 1 and 2A. This compound also inhibited the appearance of apoptosis in fresh human leukaemia cells that had been exposed to gamma-radiation. The inhibition of apoptosis was confirmed using fluorescence microscopy and DNA gel electrophoresis. Dephosphorylation of a limited number of proteins was shown to be associated with apoptosis and okadaic acid prevented these dephosphorylations. Previous studies on the BM13674 cell line showed that an inhibitor of protein synthesis failed to prevent apoptosis in these cells. The present data provides further support that posttranslational modification of proteins, in particular, phosphorylation/dephosphorylation status, plays an important role in inhibition/activation of programmed cell death in different human cells after exposure to several cytotoxic agents.
authors.affiliation: Queensland Cancer Fund Research Unit, Queensland Institute of Medical Research, Brisbane, Australia.
authors.forename: Q
authors.initials: Q
authors.lastname: Song
authors.forename: G D
authors.initials: GD
authors.lastname: Baxter
authors.forename: E M
authors.initials: EM
authors.lastname: Kovacs
authors.forename: D
authors.initials: D
authors.lastname: Findik
authors.forename: M F
authors.initials: MF
authors.lastname: Lavin
mesh_terms: D000081:Acetamides; D000470:Alkaloids / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D044182:Benzylisoquinolines; D002051:Burkitt Lymphoma / Q000473:pathology; D002273:Carcinogens / Q000494:pharmacology; D002945:Cisplatin / Q000494:pharmacology; D004988:Ethers, Cyclic / Q000494:pharmacology*; D005720:Gamma Rays; D006801:Humans; D007938:Leukemia / Q000145:classification / Q000473:pathology; D009363:Neoplasm Proteins / Q000378:metabolism; D019319:Okadaic Acid; D010766:Phosphorylation / Q000187:drug effects; D011714:Pyrans; D013141:Spiro Compounds; D014407:Tumor Cells, Cultured / Q000187:drug effects* / Q000528:radiation effects
chemical_list: D000081:Acetamides; D000470:Alkaloids; D000970:Antineoplastic Agents; D044182:Benzylisoquinolines; D002273:Carcinogens; D004988:Ethers, Cyclic; D009363:Neoplasm Proteins; D011714:Pyrans; D013141:Spiro Compounds; C059975:bistratene A; D019319:Okadaic Acid; C009438:tetrandrine; D002945:Cisplatin